Job Description
This job is with Pfizer, an inclusive employer and a member of myGwork – the largest global platform for the LGBTQ+ business community. Please do not contact the recruiter directly. Obesity Commercial Lead (Pre-Launch), ICO Role Summary The Obesity Commercial Lead (s) (Pre-Launch) is a senior, high-impact commercial leadership role accountable for shaping the International pre-launch strategy and setting up Pfizer's emerging Obesity portfolio for sustained growth across diverse markets. As part of the International Commercial Office (ICO) and in close partnership with US and Country teams, this role defines where to play and how to win -making clear, data and insight-based choices that direct investment, sequencing, and execution priorities across International to build a winning Obesity category. This role will lead with AI and demonstrate the potential of this technology to transform all phases of our launch. As assets progress through late-stage development, the role translates clinical evidence into differentiated value propositions, anticipates competitor and market dynamics, and builds an integrated International commercial strategy. This includes defining internal strategic positioning frameworks and unbranded disease‑state narratives, launch sequencing, and scalable go‑to‑market frameworks, with all external‑facing materials subject to Medical, Legal, and Compliance approval. Success requires a strong commercial mindset-grounding strategy in deep understanding of unmet needs, motivations, barriers to adoption and persistence, and the full treatment experience-while balancing HCP, self-pay/payer/access, and policy realities to maximise long-term portfolio value. Act as the primary International commercial partner to China for the upcoming GLP‑1 launch, supporting strategy, positioning, launch readiness and execution for Pfizer's first entry into the Obesity category. The role requires senior-level strategic and transformational leadership-integrating evidence, insights and stakeholder needs into enterprise-aligned recommendations and decisive, prioritised plans. In a highly matrixed environment, the individual demonstrates strong judgement, constructs clear decision narratives, and drives alignment across countries and US/Comm Dev Obesity -ensuring that the right decisions are made at the right time. The role leads cross-functional integration across Marketing, Sales, Access, Medical, Supply and Operations to convert strategy into executable, winning plans. This role is currently one of four critical leadership positions in ICO responsible for ensuring Pfizer's Obesity assets enter International markets with clear differentiation, strategic coherence, and executional readiness. The Obesity Commercial Lead elevates and aligns key pre-launch decisions - including prioritisation, investment trade-offs, evidence generation implications, and launch sequencing-with pace and rigor. Given the scale and complexity of the Obesity category, we seek agile leaders who thrive on accountability, apply creative problem solving, and consistently make winning choices rooted in patient/consumer insight, market realities, and enterprise value. All responsibilities are executed in accordance with Pfizer policies on pre‑launch and pre‑approval and communication guidance. Role Responsibilities Lead development of International pre‑launch internal marketing and brand strategy frameworks, focused on disease awareness, market development, and launch readiness. Champion a patient mindset by building deep insight into unmet need, motivations, barriers to adoption and persistence, and the end-to-end treatment experience; embed these insights into positioning, messaging, and journey design. Use integrated competitive intelligence, market research, real-world insights and KOL/customer input to drive decision quality and sharpen differentiation across International markets. Assess market potential and headroom for growth of new brands to accelerate launch uptake across International, defining where to play and the implications for sequencing and resourcing. Define customer segmentation and targeting across stakeholder groups (patient self-pay, HCP, payer/access, policy), ensuring strategy and execution reflect local market realities while remaining globally coherent. Lead development of foundational International brand strategic frameworks, including channel and content strategy, investment/spend guidance and internal governance for HCP and patient engagement, with Medical Affairs owning scientific exchange and external content delivery during pre‑approval phases. Develop scenario-based analyses to inform International decisions on launch readiness, prioritisation, and investment t